IMRX — Immuneering Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Immuneering, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	37.1	149	106	85.7	36.1
Net Total Accounts Receivable
Net Total Receivables	0.5	0.246	0.012	0	—
Prepaid Expenses
Total Current Assets	37.7	152	109	89.1	39.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.677	6.13	5.78	5.4	4.79
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	38.4	167	122	103	52.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.26	5.63	8.05	7.85	7.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.8	10.7	12.5	12	11.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	35.6	156	110	90.6	41.4
Total Liabilities & Shareholders' Equity	38.4	167	122	103	52.7
Total Common Shares Outstanding